0001493152-23-005412.txt : 20230217
0001493152-23-005412.hdr.sgml : 20230217
20230217151502
ACCESSION NUMBER: 0001493152-23-005412
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230215
FILED AS OF DATE: 20230217
DATE AS OF CHANGE: 20230217
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Bentovim Lyron L
CENTRAL INDEX KEY: 0001326879
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40556
FILM NUMBER: 23642097
MAIL ADDRESS:
STREET 1: 60 CUTTER MILL ROAD
STREET 2: GREAT NECK
CITY: NEW YORK
STATE: NY
ZIP: 11021
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Glimpse Group, Inc.
CENTRAL INDEX KEY: 0001854445
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING SERVICES [7371]
IRS NUMBER: 812958271
STATE OF INCORPORATION: NV
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 15 WEST 38TH ST, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
BUSINESS PHONE: 917-292-2685
MAIL ADDRESS:
STREET 1: 15 WEST 38TH ST, 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10018
4
1
ownership.xml
X0306
4
2023-02-15
0
0001854445
Glimpse Group, Inc.
VRAR
0001326879
Bentovim Lyron L
15 WEST 38TH ST, 12TH FLOOR
NEW YORK
NY
10018
1
1
0
0
Chief Executive Officer
Stock Options (right to buy)
7.00
2023-02-15
4
A
0
1210000
0
A
2023-02-15
2033-02-15
Common Stock
1210000
1210000
D
On February 15, 2023, the Company, under its 2016 Incentive Plan, issued to Mr. Bentovim options (the "Options") to purchase 1,210,000 shares of Common Stock, subject to the terms and conditions of Mr. Bentovim's Options Agreement, which include certain provisions set for in the Remarks section below.
The beneficial ownership set forth above does not include 37,224 shares directly held by Mr. Bentovim, 90,188 options to purchase common stock held by Mr. Bentovim, as well as 1,001,945 shares indirectly held by Mr. Bentovim (through Darklight Partners LLC - an entity owned and managed by Mr. Bentovim).
(i) an exercise price equal to $7.00 per share of Common Stock;
(ii) expiration of the Options on the Tenth (10) anniversary of the Grant Date;
(iii) all Options to vest over four (4) years commencing on February 15, 2023;
(iv) certain Options shall vest in fixed amounts, based on achieving revenue targets of $30,000,000, $50,000,000, $75,000,000 and $100,000,000 over consecutive four quarter periods in the aggregate over the next 7 years; and
(v) certain Options shall vest to each grantee in fixed amounts, based on achieving fifteen consecutive closing trading priced equal to or above $20, $30, $45 and $60 per share over the next 7 years.
/s/ Lyron Bentovim
2023-02-17